High-performance Liquid Chromatography Market to be Worth $7.9 Billion by 2030

Meticulous Research®, a prominent market research firm, released a report titled, ‘High-performance Liquid Chromatography (HPLC) Market by Product (System, Column, Reagents, Syringe Filter, Tubing, Detector, Pump, Fraction Collector, Software) End User (Pharmaceutical, Food & Beverage, Academic & Research) – Global Forecast to 2030.’
Meticulous Research® has recently published a report indicating that the high-performance liquid chromatography (HPLC) market is expected to reach $7.9 billion by 2030, growing at a CAGR of 5.2% from 2023 to 2030. The market's expansion is fuelled by increased R&D investments in the pharmaceutical and biotechnology sectors, technological advancements in HPLC, heightened food safety concerns, and strict environmental regulations. However, the substantial cost of HPLC instruments significantly hampers market growth.
Emerging economies and the establishment of bio-clusters to promote research present opportunities for market expansion. Nevertheless, the shortage of skilled HPLC professionals and the growing use of refurbished HPLC instruments pose significant challenges to the market's growth.
Key Players
Major companies in the HPLC market include Waters Corporation (U.S.), Shimadzu Corporation (Japan), Danaher Corporation (U.S.), Bruker Corporation (U.S.), Merck KGaA (Germany), Agilent Technologies, Inc. (U.S.), PerkinElmer, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Sartorius AG (Germany), Gilson, Inc. (U.S.), Tosoh Corporation (Japan), Hitachi, Ltd. (Japan), and JASCO Corporation (Japan).
The HPLC market is categorized by Product (HPLC Systems, Consumables {Columns [Pre-Packed Columns, Empty Columns], Reagents & Buffers, Vials, Fittings & Tubings, Syringe Filters, Well Plates, Other Consumables}, Components & Accessories {Detectors & Lamps, Pumps, Fraction Collectors, Other Components & Accessories}, and Software & Service); End User (Pharmaceutical & Biopharmaceutical Companies, Academic & Res

High-performance Liquid Chromatography Market to be Worth $7.9 Billion by 2030

Meticulous Research®, a prominent market research firm, released a report titled, ‘High-performance Liquid Chromatography (HPLC) Market by Product (System, Column, Reagents, Syringe Filter, Tubing, Detector, Pump, Fraction Collector, Software) End User (Pharmaceutical, Food & Beverage, Academic & Research) – Global Forecast to 2030.’
Meticulous Research® has recently published a report indicating that the high-performance liquid chromatography (HPLC) market is expected to reach $7.9 billion by 2030, growing at a CAGR of 5.2% from 2023 to 2030. The market's expansion is fuelled by increased R&D investments in the pharmaceutical and biotechnology sectors, technological advancements in HPLC, heightened food safety concerns, and strict environmental regulations. However, the substantial cost of HPLC instruments significantly hampers market growth.
Emerging economies and the establishment of bio-clusters to promote research present opportunities for market expansion. Nevertheless, the shortage of skilled HPLC professionals and the growing use of refurbished HPLC instruments pose significant challenges to the market's growth.
Key Players
Major companies in the HPLC market include Waters Corporation (U.S.), Shimadzu Corporation (Japan), Danaher Corporation (U.S.), Bruker Corporation (U.S.), Merck KGaA (Germany), Agilent Technologies, Inc. (U.S.), PerkinElmer, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Sartorius AG (Germany), Gilson, Inc. (U.S.), Tosoh Corporation (Japan), Hitachi, Ltd. (Japan), and JASCO Corporation (Japan).
The HPLC market is categorized by Product (HPLC Systems, Consumables {Columns [Pre-Packed Columns, Empty Columns], Reagents & Buffers, Vials, Fittings & Tubings, Syringe Filters, Well Plates, Other Consumables}, Components & Accessories {Detectors & Lamps, Pumps, Fraction Collectors, Other Components & Accessories}, and Software & Service); End User (Pharmaceutical & Biopharmaceutical Companies, Academic & Res